Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00687414 · ClinicalTrials.gov registry record
Evaluation of Formin Gene Status and Expression in Myeloproliferative and Myelodysplastic Disorders
A clinical trial, sponsored by Corewell Health West.
- Completed
- Registry status
- 60
- Enrollment target
NCT00687414 is a clinical trial that has completed, run by Corewell Health West. The registered enrollment target is 60 participants.
The verdict
NCT00687414 has completed, sponsored by Corewell Health West.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
Aim of the study is to analyze the expression of genes and sequences encoding the human mammalian diaphanous (mDia) related formin proteins to test the hypothesis that defects in the mDia expression or function might drive the pathophysiology of myelodysplastic syndrome, acute myeloid leukemia and other myeloproliferative diseases.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-04 |
| Est. Completion | 2010-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00687414
The ClinicalTrials.gov registry entry for NCT00687414 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health West, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00687414 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00687414 about?
NCT00687414 is a clinical study titled "Evaluation of Formin Gene Status and Expression in Myeloproliferative and Myelodysplastic Disorders". Aim of the study is to analyze the expression of genes and sequences encoding the human mammalian diaphanous (mDia) related formin proteins to test the hypothesis that defects in the mDia expression or function might drive the pathophysiology of myelodysplastic syndrome, acute myeloid leukemia and o...
What is the current status of trial NCT00687414?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2008-04. Estimated completion is 2010-01.
Who is sponsoring clinical trial NCT00687414?
This trial is sponsored by Corewell Health West, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.